BridgeMD
Compares treatment options for Glaucoma, Neovascular
Official title Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
ClinicalTrials.gov ID: NCT03648814
What this study is testing
- What it's testing
- To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of neovascular glaucoma
- The patients having IOP \> 21 mmHg, having the indication for trabeculectomy
- The patients' age of at least 18-year-old
- The patients having visual potential at least hand motion.
- Present of NVI or NVA.
You likely can't join if
- One eye patient
- Patients having severe corneal edema or total hyphema obscure NVI or NVA view.
- Cannot obtain endothelial cell count.
- History of bevacizumab or fluorescence dye allergy.
- Active infectious ocular disease including endophthalmitis and corneal ulcer
- History of systemic disease including ischemic heart disease, cerebrovascular disease, end-stage renal disease, liver failure, uncontrolled...
See the full eligibility criteria
- Diagnosis of neovascular glaucoma
- The patients having IOP \> 21 mmHg, having the indication for trabeculectomy
- The patients' age of at least 18-year-old
- The patients having visual potential at least hand motion.
- Present of NVI or NVA.
- Willing and able to provide informed consent to participate in the study
- Able to understand the purpose of the study, his/her role, and is available to return to the clinic/hospital for all required follow-up visits
- One eye patient
- Patients having severe corneal edema or total hyphema obscure NVI or NVA view.
- Cannot obtain endothelial cell count.
- History of bevacizumab or fluorescence dye allergy.
- Active infectious ocular disease including endophthalmitis and corneal ulcer
- History of systemic disease including ischemic heart disease, cerebrovascular disease, end-stage renal disease, liver failure, uncontrolled hypertension
- Has or planning to be pregnant or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Hat Yai, Changwat Songkhla, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hat Yai, Changwat Songkhla, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.